hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis.

doi:10.12659/MSM.938012

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis.

Medical science monitor : international medical journal of experimental and clinical research - 31 Oct 2022

Xu Hanjiang, Zhang Meng, Hao Zongyao, Liang Chaozhao

Abstract excerpt

BACKGROUND We performed a case-control study and an updated meta-analysis to assess the relationship between the hOGG1 rs1052133 polymorphism and prostate cancer (PCa) risk. MATERIAL AND METHODS We recruited 160 PCa cases and 243 healthy controls. For the meta-analysis, relevant studies were recruited from diverse databases up to April 2022. Genetic risk was evaluated by using an odds ratio (OR) with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to China

Share to DNA Glycosylases

Share to Genetic Predisposition to Disease

Share to Odds Ratio

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 36310366
DOI: 10.12659/MSM.938012
PMCID: PMC9635216

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis.PMID 36310366Read ↗

Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population.Semantic proximity Read ↗

Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.Semantic proximity Read ↗

The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.Semantic proximity Read ↗

Association between lncrna PCGEM1 polymorphisms and prostate cancer risk.Semantic proximity Read ↗

Meta-analysis of genome-wide and replication association studies on prostate cancer.Semantic proximity Read ↗

12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese populationSemantic proximity Read ↗

Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between APE1 rs1760944 and rs1130409 polymorphism with prostate cancer risk: A systematic review and meta-analysis.Semantic proximity Read ↗

Genetic and Pathway Alterations of Prostate Cancer: In Localized and Metastatic Prostate CancerSemantic proximity Read ↗

Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men.Semantic proximity Read ↗

Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate CancerSemantic proximity Read ↗

X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.